Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hemispherian
company
About
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €7.50M
- Industries
- Biotechnology,Consulting,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€10M
Hemispherian has raised a total of
€10M
in funding over 2 rounds. Their latest funding was raised on
Oct 19, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 19, 2022 | Series Unknown | €7.50M | 1 |
European Innovation Council
|
— | Detail |
| Oct 19, 2022 | Grant | €2.50M | 1 |
European Innovation Council
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Hemispherian is funded by 1 investors.
European Innovation Council
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
